ID   VJ-300
AC   CVCL_X217
SY   KB/VJ300
DR   ChEMBL-Cells; CHEMBL4513114
DR   ChEMBL-Targets; CHEMBL4513128
DR   PubChem_Cell_line; CVCL_X217
DR   Wikidata; Q54993183
RX   PubMed=2568984;
RX   PubMed=2906349;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 15
RX   PubMed=2568984; DOI=10.1111/j.1349-7006.1989.tb02339.x;
RA   Asoh K.-i., Saburi Y., Sato S.-i., Nogae I., Kohno K., Kuwano M.;
RT   "Potentiation of some anticancer agents by dipyridamole against
RT   drug-sensitive and drug-resistant cancer cell lines.";
RL   Jpn. J. Cancer Res. 80:475-481(1989).
RX   PubMed=2906349; DOI=10.1111/j.1349-7006.1988.tb01550.x;
RA   Kohno K., Kikuchi J., Sato S.-i., Takano H., Saburi Y., Asoh K.-i.,
RA   Kuwano M.;
RT   "Vincristine-resistant human cancer KB cell line and increased
RT   expression of multidrug-resistance gene.";
RL   Jpn. J. Cancer Res. 79:1238-1246(1988).